CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Ridloff Elena Director | Sale 10b5-1 | −7,400 | $85.37 | $632K | 0 |
| 2026-03-31 | Ridloff Elena Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,400 | 4,600 | ||
| 2026-03-31 | Chadwick Jeremy G Chief Operating Officer | Option exercise 10b5-1 | +7,600 | $29.64 | $225K | 68,802 |
| 2026-03-31 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −7,600 | $85.38 | $649K | 61,202 |
| 2026-03-31 | Chadwick Jeremy G Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,600 | 83,273 | ||
| 2026-03-25 | Chadwick Jeremy G Chief Operating Officer | Option exercise 10b5-1 | +24,727 | $29.64 | $733K | 85,929 |
| 2026-03-25 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −24,727 | $80.26 | $2.0M | 61,202 |
| 2026-03-25 | Chadwick Jeremy G Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,727 | 90,873 | ||
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Option exercise 10b5-1 | +84,400 | $29.64 | $2.5M | 152,452 |
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −22,756 | $76.73 | $1.7M | 129,696 |
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −52,975 | $77.21 | $4.1M | 76,721 |
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −8,214 | $78.40 | $644K | 68,507 |
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −6,105 | $79.87 | $488K | 62,402 |
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −1,200 | $80.05 | $96K | 61,202 |
| 2026-03-23 | Chadwick Jeremy G Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −84,400 | 115,600 | ||
| 2026-03-20 | Esposito Pamela Director | Option exercise 10b5-1 | +2,500 | $49.10 | $123K | 2,500 |
| 2026-03-20 | Esposito Pamela Director | Sale 10b5-1 | −700 | $77.71 | $54K | 1,800 |
| 2026-03-20 | Esposito Pamela Director | Sale 10b5-1 | −600 | $79.24 | $48K | 1,200 |
| 2026-03-20 | Esposito Pamela Director | Sale 10b5-1 | −1,200 | $79.94 | $96K | 0 |
| 2026-03-20 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 0 |
Page 14 of 25 · 493 trades